| Literature DB >> 33249099 |
Derek J Knight1, Hubert Deluyker2, Qasim Chaudhry3, Jean-Marc Vidal4, Alie de Boer5.
Abstract
Safety assessment of chemicals and products in the European Union (EU) is based on decades of practice using primarily animal toxicity studies to model hazardous effects in humans. Nevertheless, there has been a long-standing ethical concern about using experimental animals. In addition, animal models may fail to predict adverse effects in humans. This has provided a strong motivation to develop and use new approach methodologies and other alternative sources of evidence. A key challenge for this is integration of evidence from different sources. This paper is a call for action with regard to development, validation, and implementation of modern safety assessment approaches for human health assessment by means of focused applied research and development with three strands: (a) to improve screening and priority setting, (b) to enhance and partially replace animal studies under the current regulatory schemes and eventually (c) to fully replace animal studies, while achieving at least the same level of protection. For this gradual but systematic replacement of animal studies, a long-term concerted and coordinated effort with clear goals is needed at EU level, as a societal and political choice, to plan and motivate research and innovation in regulatory safety assessment.Entities:
Keywords: 3Rs; Animal welfare; Cosmetics; Food safety; Medicines; New approach methods; Next generation risk assessment; Non-animal-based testing; Risk assessment; Toxicology
Mesh:
Substances:
Year: 2020 PMID: 33249099 DOI: 10.1016/j.yrtph.2020.104837
Source DB: PubMed Journal: Regul Toxicol Pharmacol ISSN: 0273-2300 Impact factor: 3.271